Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes

• Main Authors: Fatmah Ali S. Alasmary (Author), Dalal A. Abdullah (Author), Vijay H. Masand (Author), Abir Ben Bacha (Author), Abdelsattar Mansour Omar Ebeid (Author), Moustafa E. El-Araby (Author), Ahmed M Alafeefy (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Quinoxalines are benzopyrazine derivatives with significant therapeutic impact in the pharmaceutical industry. They proved to be useful against inflammation, bacterial, fungal, viral infection, diabetes and other applications. Very recently, in January 2024, the FDA approved new quinoxaline containi...